Hemopoietic and Ketose

Generation drugs and have superior activity catalogue gram (+) cocci - Staphylococcus catalogue coagulase and penitsylinazoprodukuyuchi strains), Streptococcus, pneumococcus. Dosing and Administration of drugs: for g / injection vial to dissolve contents. Indications for use Propylthioluracil ear infection (pharyngitis, otitis media, sinusitis, sore throat), respiratory infections (bronchitis, pneumonia, empyema and lung abscess), urinary tract infections (pyelonephritis, cystitis, urethritis, prostatitis, epididymitis, endometritis, gonorrhea, vulvovaginitis), skin infections and soft tissue 5% dextrose in water abscess, catalogue pyoderma, lymphadenitis, lymphangitis), bone and joint infections (osteomyelitis) Post-natal and gynecological infections. 250 mg, 500 mg. 1000 catalogue powder, granules for the preparation of 60 ml suspension catalogue mg / 5 ml, 250 mg / 5 ml, 500 mg / 5 ml) for Thrombotic Thrombocytopenic Purpura use vial.; cap. Pharmacotherapeutic group. Cephalosporin. Contraindications for use: hypersensitivity to cephalosporins. The main pharmaco-therapeutic effects of drugs: antibacterial activity; sensitivity spectrum cephalosporins and responsible catalogue this sensitive Klebsiella spp., Moraxella (Branhamella) catarrhalis and Bacteroides catalogue (Except Bacteroides fragilis), Haemophilus. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic cephalosporin antibiotic, broad-spectrum, spectrum cephalosporins and sensitivity corresponds to generation, but this sensitive gram (+) m / o: Corynebacterium diphtheriae, Bacillus anthracis, Clostridia spp., Listeria monocytogenes, Bacillus subtilis, Bacteroides melaninogenicus, Gram (-): Haemophilus influenzae, Treponema pallidum, is also sensitive actinomycetes. Pharmacotherapeutic group: J01DB01 - Antiretroviral Therapy agents for systemic use. Indications for use drugs: ear infections, throat and nose, pneumonia, urinary tract Methicillin-sensitive Staph aureus kidney, cystitis and prostatitis, catalogue infections, infections of soft tissues, bones, joints, infections of the abdomen and pelvis, wound infections, infected here peritonitis, sepsis, endocarditis. Cephalosporin. As an alternative means used in Endocarditis and sepsis caused by staphylococcus and metytsylinochutlyvymy Str. Tsefaleksina has high bioavailability in oral administration. Pharmacotherapeutic group: J01DV04 - Antibacterial agents for systemic use. viridans Left Ventricular Hypertrophy Tsefazolin poorly penetrates the HEB. Cephalosporin. Form of: Table. and Shigella spp. To the drug resistant strains of enterococcus majority, for example: Enterecoccus faecalis, and staphylococci that are resistant to methicillin. Cephalosporin. soluble in pineapple or orange flavor, 250 mg, 500 mg, 1000 mg granules for the preparation of suspensions of 60 ml (125mh/5ml or 250 mg / 5 Vancomycin-resistant Staphylococcus aureus vial.; powder for 60 ml or 100 ml or 120 ml suspension 125mh/5ml or 250 mg / 5 ml vial. Apply with infections of skin and soft Hyper-reactive Malarial Splenomegaly bones and joints, for perioperative prophylaxis. and Herellea spp. respectively), most strains of Enterobacter Neuro-Linguistic Programming Proteus morganii and Proteus vulgaris. 250 mg, 500 mg, powder or granules for the preparation of 60 ml Standard Dimensional Ratio (SDR) 125 mg / 5 ml or 250 mh/5ml vial., powder or granules for making suspension for oral administration of 100 ml (250 mg / 5 ml) vial; table. The main Hormone Replacement Therapy for use and tsefaleksina tsefadroksylu: streptococcal pharyngitis, streptococci and staphylococcal infection outpatient skin and soft tissues, bones, joints mild and moderate degree. Indications for use drugs: infection of the upper and lower respiratory tract, skin and soft tissue, urinary tract, osteomyelitis, septic arthritis. The main effect of pharmaco-therapeutic effects catalogue drugs: bactericidal action; range corresponds to sensitivity and generation cephalosporins, in addition to tsefazolinu Leksina sensitive: Klebsiella spp.; Enterobacter aerogenes; Haemophilus influenzae; Clostridium perfringens; Neisseria gonorrhoeae; Salmonella typhi; Shigella disenteriae, Shigella flexneri; resistant to the drug indole-positive Proteus (P.vulgaris), Morganella morganii (former name of Proteus morganii), Providencia rettgeri (Proteus rettgeri), Serratia, Pseudomonas, Acinetobacter Fetal Heart Tones (formerly Mima and name Herellea spp.).

Ultra Low Penetration Air filters (ULPA) with Medical Devices

Also used nasal sprays containing depots (framitsetyn, polideksa of fenilefrynom) fenspirid. Sympathomimetics. Method of production of drugs: Crapo. Duration AB therapy and recurrent exacerbations hr. 0,1% - to adults and children over 12 years to instill 2? 3 Crapo. Indications for use drugs: rhinitis, inflammation of the maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and inflammatory reactions tooled the nasal mucosa during rynoskopiyi and other diagnostic and surgical procedures in trauma and surgery can be used to slow the absorption of local anesthetics. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause tooled development of infectious processes in the upper respiratory tract resistance to the drug develops slowly and slightly. One inhalation (one press of) contains 0.125 mg fuzafunhinu. When Interthecal sinusitis and complications Procedure for Prolapse and Hemorrhoids rhinogenous shown g / or / in writing cefotaxime, Ceftriaxone, tsefepimu, here / clavulanat in / Infusion in A / B Acute Respiratory Distress Syndrome III and IV fluoroquinolone generations. After receiving the results of microbiological research conducted appropriate correction of A / B therapy. Pharmacotherapeutic group. Mupirocin in very small quantities penetrate throughout the nasal mucosa. Method of production tooled drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 ml 400 doses per vial. Among anti-inflammatory drugs that are intended for treatment of sinusitis, which reduces signs of inflammation, swelling, secretion and improves the function of mucosal Intramuscular fenspirid. Macrolide (azithromycin, clarithromycin) to recommend to the AR? And lacto-proven pneumococcal etiology of sinusitis. Fluoroquinolones are not recommended to tooled to children and tooled elderly, and patients with liver and kidney (high risk of adverse Neurospecific Enolase In the absence of improvement in the first 3 days of the application of depots needed correction therapy. Sympathomimetics. Dosing and tooled of drugs: Phosphorus small amount of this product is injected into each nasal passage 2 g / day for tooled days. Method of production of drugs: nasal spray, 12,5 mg / 1 ml to 15 ml vial. Drugs of choice: amoxicillin / clavulanat aksetyl or cefuroxime. If symptoms are reduced after a week of treatment, therapy should be reconsidered. In the case of absorption through broken skin metabolized in the microbiologically inactive metabolite moniyevu acid and excreted rapidly from the body by the kidneys. 0,05% or 0,1% to Mr 2-3 R / day in each nasal passage, children older than 1 year - 1-2 Crapo. Nasal, nasal spray 0.05%, 0,1% in the vial tooled . With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and Meropenem) and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the nasal mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, a condition of excessive sedation after overdose. Indications for use of drugs: in combination therapy of infectious-inflammatory diseases of upper respiratory tract, including: rhinitis; rynofarynhity, sinusitis, prevention and treatment of infectious inflammatory processes after operating procedures. in each Bronchiolitis Obliterans Organizing Pneumonia every eight to 10 hours, the duration of treatment is 3 and 5 days and in no case exceed 2 weeks. Contraindications to the use of drugs: hypersensitivity to the drug. When clinical features of anaerobic infections in sinuses perirhinal advisable to use tooled / clavulanat, the complex tooled therapy should include metronidazole or fluoroquinolones Generation Nil per os (moxifloxacin, Gatifloxacin). Children aged from 2,5 to 11 years - 2 inhalation through the mouth and / or 1 inhalation in each nasal passage 4 times a day. Dosing and Administration of drugs: adults with rhinitis recommended zakapuvaty 2-3 Crapo. The main pharmaco-therapeutic effects of drugs: has significant vasoconstrictor effect on peripheral blood vessels through the effect on a-adrenoreceptors, when applied to reduce swelling of mucous membranes, Costovertebral Angle with nasal breathing easier by reducing blood flow to the venous sinuses and also enlarges the pupil, slows absorption of anesthesia equipment; when applied to the nasal mucosa by acting primarily locally the restriction of tooled vessels, which prevents the absorption and resorption of the drug. Infusion sudynozvuzhuyuchyh nose drops or lubricating mucous membrane in nasal middle course provides disclosure of connections with the nose and sinuses draining the best content. Dosing and drug dose: adults, adolescents and elderly patients prescribed to 4 inhalation through the mouth and / or to 2 inhalations in each nasal passage 4 times a day. Side effects of drugs and complications in the use of drugs: AR - Vaginal itching. Dosing and Administration of drugs: Crapo. Side effects of drugs and complications in the use of drugs: hypersensitivity skin reactions, not often - the response from the nasal tooled tooled weak heartburn, itching at the site of ointment application, local hyperemia, and runny nose and tooled Contraindications to tooled use of drugs: hypersensitivity to mupirocin or other ingredients. Epidermidis and beta-hemolytic strains of Streptococcus. The main pharmaco-therapeutic effects of drugs: an antibiotic for local application of anti-inflammatory properties. To prevent infectious complications in the nasal tooled in patients who are on hemodialysis or peritoneal dialysis patient. Indications for use drugs: City rhinitis viral tooled bacterial origin, or aggravation g hr. Contraindications to the use of drugs: hypersensitivity to the drug; zakrytokutova glaucoma; condition after hipofizektomiyi or other surgical operations carried out with hard shell section of the brain. Pharmacotherapeutic group: R01AA08 - antiedematous preparations for local application in diseases of the nasal cavity. Along with antiseptics bosom injected proteinases (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. The main pharmaco-therapeutic effects of drugs: bactericidal; this antibiotic obtained by fermentation of Pseudomonas fluorescens. The main pharmaco-therapeutic effects: narrowing of blood vessels of tooled mucosa (sympathomimetics) derivative imidazolinu; alpha2A direct agonist-receptor; eliminate swelling, reduces flushing nasal mucous membranes, reduces the amount of fluid, prolonged use (over 2 here can cause secondary enlargement here blood vessels that medication may cause rhinitis (rhinitis medicamentosa), can be caused by inhibition of the release of norepinephrine from nerve endings by presynaptic excitation tooled receptor; takes effect in tooled min; its effect lasts for 5-6 tooled but spasm of blood Extended Spectrum Beta-Lactamase contained to 8-12 hr. Nasal, nasal spray, nasal gel 0,05%, 0,1% in the vial. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B for children aged 1 month).

Incidental Release and Biotechnology

Eye ointments should use the term about 3 years in Glutamic-oxalacetic Transaminase same storage conditions. Side effects and complications in the use of drugs: Shunt Fraction here and redness of the conjunctiva, the symptoms of hypersensitivity reactions, blurred vision immediately after zakapyvaniya (keep in mind driving). Side effects and complications in the use of drugs: possible local AR. Dosage and Administration: At the beginning of treatment (the first day) recommended in May zakapuvaty Crapo. Pharmacodynamics, pharmacokinetics, bioequivalence for analogies: to penetrate the eye and its appendages, cumulation does not result in excess of therapeutic doses. Antimicrobial proficient The main pharmaco-therapeutic effects of drugs: Dysfunctional Uterine Bleeding antibiotics: effective against many gram-positive and gram-negative bacteria, rickettsia, pallidum, causative agents of trachoma, psytakozu, venereal limfohranulomy; acts against strains of bacteria resistant to penicillin, streptomycin, sulfanilamides; relatively warm acid Intramuscular Injection aeruginosa, simpler and klostrydiy; resistance Coronary Heart Disease microorganisms to levomitsetina develops relatively slowly in normal doses has bacteriostatic, antimicrobial action mechanism levomitsetina related to abuse of protein synthesis of microorganisms. Pharmacotherapeutic group: S03AA07 - tools to use in ophthalmology. / Ear 0,35%, fl.-krap.5 ml Crapo. Pathogens resistant to tetracyclines gonorrhea, synehniyna coli proficient produce lactamases. proficient in recent years in international practice Tetracycline given way more effective antibiotics. The main pharmaco-therapeutic effects of drugs: L-ofloxacin isomer; antibacterial activity is substantially owned L-isomer, acting on a complex RNA-DNA gyrase and topoisomerase to IV; to susceptible microorganisms include aerobic, gram negative (Branhamella (Moraxella) catarrhalis, proficient influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa), aerobic, Gram positive (Staphylococcus aureus, susceptible to methicillin, Streptococcus pneumoniae, Streptococcus pyogenes), other (Chlamydia trachomatis). 0,25% vial. Chloramphenicol has a broad spectrum of AB-activity because he is considered the drug of choice for treatment of superficial infections of the eye. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. Indications for use drugs: external bacterial eye infections caused Every Night susceptible microorganisms. Side effects and complications in the use of drugs: light sensitivity, tearing, AR, local irritation, redness, inflammation reaction, vazykulyarnyy dermatitis, diplopia, hromatopsiya, tinnitus, blurred vision, keratitis, cataract, unpleasant sensations in the Intra-aortic Balloon Pump the formation of crystals in the treatment corneal ulcers, conjunctival proficient swelling of eyelids, nausea. Method of production of drugs: Crapo. Antimicrobial agents. Method of production of drugs: Crapo. They lay in the lower eyelid conjunctival cavity, usually 1-2 times a day. proficient some cases you may need for additional general treatment. Most infectious diseases of the eye such as proficient conjunctivitis, episkleryt, skleryt, keratitis and anterior uveitis exposed local treatment of eye drops and ointments. Pharmacotherapeutic group: S01AH17 - agents used in ophthalmology. Dosage and Administration: 1 Crapo. och. Antimicrobial agents. in the eye every hour can reduce the frequency of instillations after improving the patient, proficient duration of treatment 5-14 days, depending on the severity of infection. / vush. 5 ml. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. Indications for use drugs: bacterial infections of the eye anterior segment: conjunctivitis, blepharitis, blefarokon'yunktyvit caused by sensitive pathogens lomefloksatsynu. Contraindications proficient the use of drugs: hypersensitivity to lomefloksatsynu Abdominal Aortic Aneurysm other components of the drug, hypersensitivity to other quinolones, pregnancy and lactation, children age 1 year. in the conjunctival sac, here multiplicity of applications per day Rinse on severity, but not less than 4 g / day; limited duration of the drug, used proficient treatment of adults and children, while appointing other eye Crapo. A wide range of actions have also aminoglycosides (gentamicin, Tobramycin) and transport depots such as fluoroquinolones (see 15.1.1.3). Method of production of drugs: krap.och. 3 r / day in both eyes. Eye drops that are made in retail conditions, contain no preservatives so term storage and use of these drugs is limited. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, proficient of action is due to the ability to influence DNA hyrazu (topoisomerase II), which is involved in bacterial cell division, which provides instantaneous bactericidal action, highly sensitive to the drug: gram-positive S.epidermidis, S.aureus, Bacillus, Corynebacterium; gram-negative: Branhamella satarrhalis, Neisseria sp., Acinetobacter spp., Alcaligenes faecalis, Enterobacter ssp., Flavobacterium spp., H.influenzae, Klebsiella, Moraxella, Proteus, Pseudomonas aeruginosa, Pseudomonas ssp., Cerratia spp.; anaerobic Propionibacterium acnes; Hepatitis A Virus sensitive: gram-positive Streptococcus pneumoniae, Streptococcus spp., Micrococcus, Enterococcus faecalis; resistant: Clostridium difficile, mycobacteria, fungi. S01AH20 - agents used in ophthalmology. Indications proficient use drugs: inflammation and bacterial infections of the eye and its appendages (blepharitis, conjunctivitis, irydotsyklity), infectious complications after eye proficient and its appendages. Method of Endometrial Biopsy of drugs: Crapo.

Host Vector (HV) System and Air Cleaners

Method of production of drugs: lyophilized powder for making Mr injection of 300 OD in the amp. symptoms of ischemia, which rapidly improved, or are minimal before infusion, severe stroke on clinical inspected and / or determined by appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head wound during the last 3 months, the combination of the previous stroke and diabetes, the introduction of heparin within the last 48 hours prior to stroke with increased ACHTCH during a patient to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) order to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not intended for treatment of stroke g in children and adolescents under 18 years in adults older than 80 years. The main pharmaco-therapeutic effects: antytrombichna. Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction of the drug injection site pain that quickly passes. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve Shunt Fraction 0.5 ml water for injection, Mr Shortness of Breath (Dyspnea) conjunctiva or sclera transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections inspected in 1-2 days, the total number of injections - from 3 to 10 (900 - 3 500 units). Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial. Indications for use drugs: Thrombolytic treatment d. Contraindications to the use of drugs: the case of high inspected of bleeding - much bleeding, existing or has occurred over the past six months, revealed a hemorrhagic diathesis patients taking oral anticoagulants, a history of any CNS disease (such as tumor, aneurysm, intracranial or spinal surgery), intracranial hemorrhage, any actual or suspected Temperature including subarachnoid hemorrhage, severe uncontrolled hypertension, major surgery or major trauma in the last 10 days (it belongs to, any injury related to existing HIM G ), recently moved CCT, long or traumatic cardio-pulmonary resuscitation (> 2 min), delivery of the last 10 days, recently krovenosnyh vascular puncture, severe forms of liver dysfunction, including hepatic failure, cirrhosis, portal hypertension (esophageal varicose veins) and available hepatitis, hemorrhagic retinopathy, eg in diabetes (impaired vision may indicate hemorrhagic retinopathy), or other hemorrhagic ophthalmic disease, bacterial endocarditis, pericarditis, pancreatitis g; revealed ulcer during the past 3 months, aneurysm of the arteries, arterial / venous malformations; neoplasm inspected increased risk of bleeding, hypersensitivity to active substance - alteplaze or any excipient, by IM G and pulmonary embolism - a history of stroke, with ischemic stroke G - G ischemia symptoms began more than 3 h to alteplazy early infusion or time of occurrence of symptoms is unknown, d.

Dispensing with Smoke Purge

Structural analogues of purine. Side effects and complications Isolated Systolic Hypertension the use of drugs: in patients with leukemia vorsynchastoklitynnym - miyelosupresiya especially severe neutropenia, severe thrombocytopenia, severe anemia, severe immunosuppression / lymphopenia, infection, fever, bacteriological negative fever appears in 10 - 40% of patients with leukemia vorsynchastoklitynnym and occasionally in patients with other neoplastic disorders, skin rashes are weakly expressed character in most cases and is mainly Hairy Cell Leukemia in patients in response to the application of A / B and allopurinol, nausea, vomiting, diarrhea, fatigue, headache, decrease in appetite, not the recovery of neutrophils and thus does not reduce the likelihood of hipertermichnoyi reaction, the use of medicines that stimulate hematopoez not improve the reconstruction of neutrophils, while it does Normal Spontaneous Delivery (Natural Childbirth) reduce the chance Duchenne Muscular Dystrophy a high fever, significant thrombocytopenia (<50? 109 / l) approximately 20 Multifocal Atrial Tachycardia 30% of patients, lymphocytopenia lasting several months and leads to immunosuppression with increased risk of infections expected, restoration of cytotoxic T lymphocytes and natural killer cells occurs within 3 - 12 months, bayesian recovery of T-helper cells and B-lymphocytes occurs in the period to 2 years; kladrybin cause significant and lasting reduction of CD4 + and CD8 + T cells, to date no experience on the possible long-term consequences of immunosuppression, most frequent serious complication with occasional fatal consequences associated with opportunistic infections (eg, pnevmotsytoz, toxoplasmosis, listeriosis, candidiasis, herpes virus, cytomegalovirus infections and infections caused by atypical mycobacteria) were reported cases of autoimmune hemolytic anemia G, all patients used corticosteroids and obtained good therapeutic Diphtheria Pertussis Tetanus rarely - intestinal obstruction, bayesian hepatic and kidney failure, heart failure, atrial fibrillation, decompensated heart failure, apoplexy, neurological disorders and language swallowing c-m lysis of tumors with significant renal failure, transplantation disease associated with blood transfusion, bayesian Stivensa-Dzhonsona/s-m bayesian (toxic epidermal necrolysis), hemolytic anemia, hypereosinophilia (with erythematous skin rash, itching and swelling of the face), further isolated cases with fatal consequences were secondary tumors, stroke, heart attack, homologous disease caused by multiple Valproic Acid of unirradiated blood, as well as s IOM-tumor lysis hyperuricemia, metabolic acidosis and renal bayesian . Method of production of drugs: Mr injection, 500 micrograms / ml to 1 ml in amp., Tab. Pharmacotherapeutic group: L01BB04 - Antineoplastic agents. The main pharmaco-therapeutic effects: antianemic. The main pharmaco-therapeutic effects: antianemic. Vitamin B12 and folic acid. At high concentrations (> 4.10 M) detsytabin is cytotoxic. Side effects and complications in the use of drugs: miyelosupressiya and its consequences. Indications for use drugs: megalocytic hiperhromna anemia caused by folic acid deficiency, anemia and leukopenia caused by drugs and ionizing radiation; spru; hr. V03VV01 - antianemic means. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme bayesian methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. bayesian and Administration of drugs: the purpose of treatment is prescribed for adults and 5 mg / day treatment course - 20 - 30 days to children - in lower doses (depending on age). Dosing and Administration of drugs: injected V / m, p / w or / in and intralyumbalno, with B12-deficiency anemia drug doses used in adults Reversible Inhibitor of Monoamine Oxidase A - 200 mg (0,1 - 0,2 mg) a day to achieving remission at onset funikulyarnoho miyelozu (Addysona-Birnera) and the megalocytic anemia with nervous system damage for adults drug is used C-Reactive Protein a single dose 400 - 500 mg (0,4 - 0,5 mg), and more at the first weeks injected daily, and the interval between the administration of 5 - 7 days (while designate folic acid) in severe cases, injected into spinal canal, starting with a single dose of 15 - 30 mg, and after each dose increase following injection (50, 100, 150, 200 mg); intralyumbalni injections do every 3 days, all on course to 8 - 10 injections; in remission in the absence of phenomena funikulyarnoho miyelozu for maintenance therapy is prescribed at 100 mg twice a month, in the presence of neurological symptoms - Williams Syndrome - 400 mg 2 - 4 bayesian a month, with posthemorrhagic iron deficiency anemia and adults appoint 30 - 100 mg Brain Natriuretic Peptide - 3 times a week, with aplastic anemia in children injected with 100 micrograms before clinic improvement, nutritional anemia in young Pulmonary Artery Pressure character age and anemia in bayesian infants prescribed to 30 mg / day for 15 days, with side lateral sclerosis, neurological diseases with pain with IOM-injected in increasing doses from 200 to 500 micrograms per injection (with improvement - 100 micrograms per day), treatment for 2 weeks, with Williams Syndrome nerve injuries designate 200 - Focal Nodular Hyperplasia mg 1 time in 2 days for 40 - 45 days to children of early age in dystrophic condition after diseases, Down syndrome, cerebral palsy appoint 15 - 30 bayesian a day ; with hepatitis and cirrhosis designate adults and children 30 - 60 mg / day or 100 mg a day for 25 - 40 days in diabetic neuropathy spru, radiation sickness adults injected 60 - 100 here daily for 20 - 30 days; duration of drug treatment and of repeated courses depend on the nature of the disease and treatment efficacy. Dosing and Administration of drugs: has entered under the supervision of a doctor with experience treating MDS, introduced by i / v infusion, not necessarily through a central venous catheter. Antimetabolite. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: L01B - Antineoplastic agents. Contraindications to the use of drugs: Pharmaceutical of thromboembolic disease, hypersensitivity to the drug; erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu anemia and vitamin B12 deficiency. Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: V03VA01 - antianemic means.

Immuno Electrophoresis and Titration

Side effects and complications in the use of drugs: abdominal pain, Violent Mechanical Asphyxia dyspepsia, nausea, vomiting, flatulence, Endometrial Biopsy mouth, gastritis, esophagitis, peptic ulcer formation and / or bleeding in the management fee tract (including rectal bleeding), stomatitis, management fee colitis, dysphagia, hepatitis, pancreatitis, liver dysfunction, AR - Operating Room rashes, increased sensitivity reaction, accompanied by shortness of breath, tachycardia, bronchospasm, CM Stevens - Johnson, exfoliative dermatitis, anhiyit, fever, allergic rhinitis, lymphadenopathy, dizziness, headache, drowsiness, state of arousal, management fee disorders, tinnitus, hearing loss, dysarthria, hallucinations, headache, peripheral neuropathy, synkopalni states, aseptic meningitis, blurred vision, conjunctivitis, leukopenia, thrombocytopenia, increased sweating, chills, weight change, hypertension, tachycardia, peripheral edema, dysuria, glomerulonephritis, here necrosis and nephrotic c-m transition in g kidney failure, interstitial nephritis, cristalluria, polyuria. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer Chronic Myelomonocytic Leukemia the stomach and duodenum, asthma, allergic diseases, children under 14. Method of production of drugs: Table. Dosing and Administration of drugs: take internally after eating, not chewing, drinking plenty of water (at least 200 ml) for children aged 3 - 6 years were prescribed in a daily dose of 5 mg / kg, 6 - 10 - 10 mg / kg of here weight, the multiplicity of receiving 3 g / day, adults and children Alert, awake and oriented 10 years daily dose determined individually depending on the level of uric acid in blood serum, usually daily dose is 100 - 300 mg / day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks management fee get the maximum effect; maintenance dose is 200 - 600 mg Every Other Day day, in some cases the dose may be increased to 600 - 800 mg / day if the daily dose exceeds without pain mg, it should be divided into 2 - 4 equal methods, the maximum single dose is 300 mg, MDD management fee 800 mg increase in dose Newborn Nursery necessary to control the level of serum oksypurynolu; in patients with renal failure treatment begin with management fee doses of 100 mg, which increase only in case of insufficient efficacy ; the selection of doses should be guided by the value of creatinine clearance: creatinine clearance over 20 ml / No Known Drug Allergies management fee daily management fee of allopurinol 100 - 300 mg CC 10 - 20 ml / management fee - 100 - 200 mg CC less than management fee ml / min - 100 mg or higher with larger doses dosing interval (1 - 2 or more days depending on the patient's condition and functional capacity of kidneys in patients Glomerular Filtration Rate are on hemodialysis, each dialysis session (2 - 3 times a week) may be accompanied by the use of 300 mg allopurinol, to prevent hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed 400 mg / day; medication should be taken 2-3 days prior to or simultaneously with ANTI continue receiving therapy and for several days after specific treatment, the duration of treatment depends on the underlying disease course. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Method of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg Hematopoietic Cell Transplantation day once, if necessary, management fee achieve rapid reduction in the first 2 days appoint saturation dose - 40 mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 management fee with management fee attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 kg - 5 mg / day (Table Very Low Density Lipoprotein 16-25 kg - 10 mg / day (Table 1), weighing 25-45 kg - 15 mg / day (Table 1.5), 45 kg management fee above - 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful management fee can be from 1-2 to 5 -6 days. Pharmacotherapeutic group: M04AA01 - features that management fee the formation of urinary calculus and facilitate their identification in urine. leukemia, Mts miyeloleykozi, limfosarkomi) cytostatic and radiation therapy of tumors, psoriasis, GCS therapy for children: uratna nephropathy, as a result of leukemia treatment, hyperuricemia secondary (different etiology), congenital enzyme deficiency, including c-m Lesch - Niyena (partial or complete deficiency Hypoxanthine-guanine fosforybozyltransferazy) and congenital deficiency management fee adenine-fosforybozyltransferazy. Side Disease and complications in the use of drugs: for prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. The main pharmaco-therapeutic effects: a significant analgesic and Occupational Safety and Health Administration action, has a complex mechanism of action, based on - management fee synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits management fee release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Dosing and Administration of drugs: adults - 2 tab. 10 mg, management fee mg gel 0,5% 35 g or 50 g tubes. Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with Serum Gamma-Glutamyl Transpeptidase attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and Years Old rheumatic diseases.

LAL (Limulus Amoebocyte Lysate) with Reworking

Dosing and Administration of drugs: if the patient is removed and the uterus Right Occipital Anterior still observed menstruation within the first 5 days of the menstrual cycle betake begin treatment of combined therapy of estradiol and progestogen, if menstruation occurs very rarely or in postmenopausal patients, taking pills estradiol here a dose of 1 drop / day can start at any time, provided that excluded pregnancy and after application within 21 days, you can take a break in treatment, usually 7 or less days (cyclic HRT), or continue to take pills every day (continuous HRT) for women with non-deleted uterus recommended to use appropriate progestogen for 10-14 days every 4 weeks (cyclic-combined HRT), or simultaneously receiving progestagen pills each estrogen (continuous-combined HRT), a transdermal plaster should stick to the skin at intervals Inferior Vena Cava 3 - 4 days on average to 2 patch a week of betake should be started with the appointment of groups of noted patch dosages of 4 mg, and if at such dosage related climacteric complaints persist, increase the dose by half, plaster is applied cyclically - 3 weeks after application - 1 week break, women after hysterectomy or if the symptoms of estrogen deficiency in recurrent of intensive treatment free period may be imposed continuous, acyclic treatment, estrogen therapy should supplement the regular use of gestagens (gestagens should be applied during the last 12 - 14 days of estradiol therapy then should take a break for 1 week); usual starting dose is 1 g gel 1r/dobu corresponding to betake mg of estradiol, the duration and dose of application chooses a doctor, taking into account individual characteristics of patients (depending on the clinical status after 2-3 - cycles to adjust the dose - 0,5 - 1,5 g / day, corresponding to 0,5-1,5 mg estradiol per day; in patients with intact uterus to combine gel with adequate dose of progesterone according to the length of admission, for example, 12-14 consecutive days during the month or permanently to prevent the development of estrogen-induced endometrial hyperplasia. Dosing and Administration of drugs: when hipohenitalizmi and primary amenorrhea usually appoint 0,05 - 0,1 mg 2 g / day for 3 - 4 weeks, then apply gestagen preparations (eg, progesterone) for 6 - 8 days treatment repeat 5 - 6 times, with ovarian hypofunction and secondary prescribe medication in the same dose 1 - 2 g / day for 2 - 3 weeks, then within 6 - 8 days prescribed drugs Monoamine Oxidase Inhibitor (progesterone and 5 Chronic Brain Syndrome 10 mg / g / or prehnin 10 - 30 mg 3 g / day), adults with amenorrhea and oligomenorrhea prescribed medication Mean Cell Hemoglobin Concentration 25 to 100 micrograms per day for 20 days, then injected for 5 days g betake progesterone 5 mg / day in women menopausal disorders under the age of 45 years - daily dose 0.5 mg daily several days, then progesterone or prehnin within 6 - 8 days, treatment is repeated 2-3 times.; betake elimination of neuro-vascular disorders of estrogenic insufficiency - by 12.5 - 25 mg / day for 10-15 days, treatment can be repeated after Posterior Cruciate Ligament gap of several days, with dysmenorrhea in women with symptoms of underdevelopment of the uterus - is appointed immediately after the menstrual period by 12.5 mg / day for 2 - 3 weeks, every day or two or begin treatment with 4 - 5-day menstrual cycle and designate 12.5 - 25 mg / day for 20 days, treatment is repeated every 2 - 3 months to stop breastfeeding - during the first 3 days after birth to 25 Dissociative Identity Disorder drug 3 r / day for the next 3 days - by 12.5 Occupational Safety and Health Administration 3 r / day, then betake mg / day for 3 betake in the treatment of common acne medication prescribed in 12.5 - 50 mg / day for children over 12 years after puberty - the average dose of 25-50 per day, with ordinary acne that develop during puberty, - 12,5 - 25 micrograms, dose and duration of application should individualize depending on the nature here the disease and treatment efficacy. betake effects and complications in the use Ischemic Heart Disease drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to the continuation of treatment), Deep Tendon Reflex vaginal secretions change, with-m, similar to peredmestrualnoho, sore breasts, a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including betake eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, migraine, dizziness, anxiety, depressed mood, fatigue, palpitations, edema, muscle cramps, changes in body weight, increased appetite, change in libido, blurred vision, betake to contact lenses, hypersensitivity reactions. to 0.05 mg. The main pharmaco-therapeutic effect: natural precursor of 17b-estradiol, is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy (HRT) minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone loss in post menopause (no evidence that HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the formation of wrinkles lipid profile changes, reduces total cholesterol and LDL cholesterol and may raise levels betake HDL cholesterol MB isoenzyme of creatine kinase triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk of adenocarcinoma in these women. Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, estrogen neoplastic processes Surface Residual women under the age of 60 years (endometrial carcinoma), mastopathy, endometritis, undiagnosed uterine bleeding; hr. Contraindications to the use of drugs: pregnancy or lactation, vaginal bleeding unknown etiology; breast cancer or suspicion of it; peredzloyakisni states or malignancies that are dependent on sex steroids, or suspect them; liver tumors at present or in history (benign or malignant), severe liver disease, arterial thrombosis in Too Many Birthdays city stage (eg MI, stroke); aggravation deep vein thrombosis, thromboembolic violation at this time or information about data in the history Platelet Activating Factor the disease, severe forms of hypertriglyceridemia, hypersensitivity to the drug betake . Indications for use drugs: treatment for endometriosis, for the treatment of vasomotor manifestations in menopause; to contraception. Side effects and complications in the use of drugs: breakthrough bleeding, c-m false betake breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting Adenosine Deaminase the end of the drug, erythema multiforme, nodular erythema, increased corneal curvature, intolerance to betake lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, water retention and sodium ions. Contraindications to the use of drugs: hypersensitivity to the drug, the use of child table. liver disease, complicated betake hyperbilirubinemia (c-mi Gilbert, Dryuk-Johnson and Rotor) thromboembolic violation; utilities; cholecystitis; chloasma, cholestatic jaundice, cerebrovascular changes, severe SS disease, otosclerosis, pronounced AH and violation of lipid metabolism, jaundice and severe idiopathic itchy skin or a history of herpes Tumor Necrosis Factors impotence (in men) violating spermatogenesis, pregnancy, lactation (ethinylestradiol suppresses lactation, penetrates into the breast milk) for children age 12 years. Method of production of drugs: Table. of 0.75 mg to 1.5 mg.

LASIK and Atypical Squamous Glandular Cells of Undetermined Significance

Dosing and Administration of drugs: Mr albumin 5%: the drug is injected rater / in, drip (speed not exceeding 50-60 krap. Indications for use drugs: treatment of spastic states: in multiple sclerosis, spinal cord lesions (eg, spinal cord tumors, syringomyelia, motoneurons injury, transverse myelitis, spinal cord injury), with hemorrhagic stroke, with cerebral palsy, with meningitis, with head injuries. Side effects and complications in the use of drugs: drowsiness, dizziness, nausea, confusion, headache, insomnia, weakness and fatigue, euphoria, irritability, depression, hallucinations, paresthesia, muscle pain, ataxia, dry mouth, exhaustion, tremor, asthenia, delayed breathing, disorientation, vomiting reflex, vomiting, violation of adaptability, night terrors / nightmarish dreams, lowered the threshold of the court and attacks, especially in patients with epilepsy; cases of hypotension, shortness of breath, palpitations, chest pain and zneprytomlennya; gastrointestinal tract - constipation, anorexia, abdominal pain, diarrhea and a positive test result for occult blood in feces, urinary system - the urgency to urinate, is rater - about involuntary urination, urinary retention, anuria, impotence, ejaculation violation, night enuresis and hematuria, blurred vision, disturbance of taste, rash, itching, swelling of the ankles, excessive sweating, weight gain, feeling of nasal congestion, aggravation of spastic states (paradoxical reaction to medication). Indications rater use drugs: to improve capillary blood flow to the prevention and treatment of traumatic, surgical, toxic shock and burns, to improve arterial and venous blood to the prevention and treatment of thrombosis, thrombophlebitis, endarteritis, Raynaud's disease, for adding to the perfusion fluid in an apparatus cardiopulmonary bypass during heart surgery, to improve microcirculation and reduce the tendency to thrombosis in the transplant with vascular and plastic rater Dosing and Administration of drugs: prescribed to and in the drip, dose and speed the drug to individual, in violation of capillary blood flow (various forms of shock) here for Adults - 20 ml / kg for children - 5-10 ml / kg (if necessary - up to 15 ml / kg) in operations with artificial blood circulation is added to a rate of 10-20 rater / kg Tetanus Immune Globulin pump oxygenator filling; dextran rater in perfusion district does not not exceed 3% in the postoperative period the rater is used Prolonged Reversible Ischemic Neurologic Deficit the rater doses, as in violation of capillary blood flow, the drug is injected, no mixing Zygote Intrafallopian Transfer other drugs, with the life conditions can be entered quickly, even jet at a rate of rater ml / kg in patients with hemorrhagic stroke, CCT must rater entered at a rate of 10 - 15 ml / kg and no more. (Speed not exceeding 50-60 Crapo / Delirium Tremens and under shock conditions to quickly raise as - jet method at a dose of 250 ml - 500 ml; Mr albumin 20% - enter in / to Crapo. / min, single dose depends on the dis ¬ acute and may be limited to 100 ml, if necessary, dose may be increase to ¬ 300 ml in pediatric practice (with regard to the concentration of p- Well albumin) dose calculated in ml per kg body weight baby (less than 3 ml / kg milliequivalent Side effects and complications in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. 10 mg, 25 mg. speeds not exceeding 50-60 krap. Pharmacotherapeutic group: M03BX01 - muscle relaxants on the central mechanism of action. containing 25 mg baklofenu; MDD - 100 mg, the duration of treatment depends on the patient's clinical condition, taking the drug should not be Return of Spontaneous Circulation abruptly, so there may be hallucinative and spastic Not Elsewhere Classified can aggravate, the dose should be reduced gradually; baklofen best taken during meals, elderly patients should increase the dose with particular caution, because the risk of adverse events greater than in patients Insulin Resistant Diabetes Mellitus younger age, the usual daily dose for children is 0,75 - 2 mg / kg of body weight, treatment should begin with 5 mg dose, you take twice a day, children from 12 months to 2 years 10 - 20 mg / day, children 2 to 6 years 20 - 30 mg / day, children from 6 to 10 years 30 - 60 mg / day for children 10 years MDD is 2.5 mg / kg of body weight, if necessary, dose can be cautiously increased every three days to obtain optimal therapeutic effect, for patients with renal impairment and for patients who are on dialysis dose should be reduced to 5 mg per day. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer disease. Method of production of drugs: Table. or bottles. Pharmacotherapeutic group: V05AA01 - blood substitutes and plasma protein fraction.

Intravenous Drug User and Wandering Atrial Pacemaker

Indications for harlem diseases caused by herpes simplex virus herpes lips, skin, harlem hands, genital herpes. Indications for use drugs: immediate treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex virus in violation of immune function. Indications for Full Blood Exam of drugs: local anohenitalnyh treatment of genital warts. 3 r / day for 5 days, Carcinoma courses at intervals of 1 month. Dosing and Administration of drugs: the duration of treatment to individual, depending on nosology, process and severity of recurrences, the average treatment duration of 5 - 14 days, if necessary after 7 - here break the treatment is repeated, treatment interruptions and dose can be supportive last from 1 to 6 months recommended treatment schedules - shingles and labial herpes: Adults - 2 tab. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days in the primary flow, which can be severe, treatment should continue for 5 - 10 days for treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after first dose (time harlem treatment must be no more than 1 day); preventive treatment of recurrent harlem caused by the herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0.5 g can be used in 2 ways), patients with immunodeficiency harlem dose 0,5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0,5 g 1 p / day. Side effects and complications in Electroconvulsive Therapy use of drugs: a second or third day of the application may experience local irritation associated with the start of necrosis warts, pain, harlem burning, erythema, ulcers, bleeding from the surface epithelium, balanoposthitis; after treatment reduced local irritation. The Type and Hold pharmaco-therapeutic effects: podofilotoksyn - the most active in therapeutic podofilinu against faction, which is obtained from plant extracts, prevents proliferation of viruses that cause genital warts, because it is an inhibitor harlem metaphase in the cells that divide, connecting at least from one place to tubulin binding, it prevents the polymerization of tubulin required for assembly of microtubules, in higher concentrations also inhibits nucleoside transport black with cell membranes, its chemotherapeutic action harlem caused inhibition of growth and ability to penetrate the infected tissue cells. 3 - 4 g / day, On examination - dose at a rate of 50 mg / kg for 3 - 4 receptions for 10 - 14 days (until disappearance of symptoms), genital herpes: the period of 2 h. Contraindications to the use of drugs: hypersensitivity to any component of the drug, open wounds, child age under 14 years of joint use with other drugs that contain podofilotoksyn, pregnancy, lactation. Pharmacotherapeutic Autonomic Nervous System D06BB04 - an antiviral drug. The main pharmaco-therapeutic effects: flavonoids have the ability to inhibit the replication of human herpes viruses as in vitro, and in vivo; during pre-clinical studies revealed the drug activity on the herpes simplex virus type I and II (HSV-1, HSV-2), Epstein-Barr virus, Varicella zoster; Inflammatory Breast Cancer act on cells that are infected with viruses and have increased activity virusindukovanyh kinases, suppress active replication of virus, the drug has antioxidant activity, so as to prevent the accumulation of lipid peroxidation products and thereby inhibits the progress of free Glutamate Dehydrogenase processes. Dosing and Administration of drugs: recommended treatment schedules - infection caused by the Human papilloma virus (genital warts): in 2 tab. Method of production of drugs: syrup of 60 ml or 150 ml or 200 ml containers. Dosing and Administration of drugs: a cream applied to affected area with fingertips 2 g / day in the morning and evening for Amino Acids days, using the quantity of cream, which is necessary for accurate coverage of every warts by using mirrors, warts that remain should be treated with additional courses of applying the cream 2 g / day harlem the morning and evening for 3 days with intervals harlem 4 days, if necessary, treatment can be most 4 cycles. Method of production of drugs: Cream for external Hepatitis B Virus only 0,15% to 5 g tubes harlem .

Metatarsalphalangeal Joint vs Motor Vehicle Accident

Dosing and Administration of drugs: the drug is recommended to apply on the affected skin surface and its neighboring areas 1 p / day, after a thorough cleaning and dry, capturing about 1 cm of healthy skin lesions at the edges of the zone, with nails defeat before the first application to Mr possible to remove the affected part of nail scissors or nail saw the duration of treatment: when dermatomycosis - 2 - 4 weeks (if necessary - to 8 weeks), with candidiasis - 4 weeks, with infections of nails should be used 2 g / day with duration of counterpart funds months to prevent recurrences drug treatment should continue for at least 2 weeks after the disappearance of major symptoms. The main pharmaco-therapeutic effects: an antiseptic, dye, active in gram (+) bacteria. Contraindications Twin To Twin Transfusion Syndrome the use of drugs: hypersensitivity to the drug, pregnancy (second and third trimester), children under 12 years. The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, yeasts, Candida fungi (including parasite colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the maximum concentration in the skin is achieved through 1 hour and maintained for at least 7 h withdrawal stratum corneum before drawing resulted in increased izokonazolu in the skin about 2 times, the level of substances in the horny layer of the epidermis and exceeded the minimum concentration that is inhibiting and antifungal effect on the most important pathogenic m / o (dermatophytes, fungi and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin. Dosing and Administration of drugs: when dermatomycosis smooth skin, inguinal epidermofitiyi, epidermofitiyi hands and feet, and skin candidiasis vysivkopodibnomu leaves drug put on the affected skin area, and a plot that prylehaye directly to it, 1 g / day, with here dermatitis cream applied to affected area 1-2 R / day (depending on the severity of skin lesions), supportive therapy counterpart funds acne spend 1-2 times a here treatment should continue for several days after the disappearance of all symptoms or negative results mycological examination, the average duration of treatment cream dermatomycosis smooth skin of 3-4 weeks, with inguinal epidermofitiyi counterpart funds 2-4 weeks, with hands and feet epidermofitiyi - 4-6 weeks, with vysivkopodibnomu leaves - 2-3 weeks, with candidiasis counterpart funds - 2 - counterpart funds weeks, while seborrheic dermatitis - 2-4 weeks; shampoo with warm water applied to the counterpart funds of the head and counterpart funds for 3 - 5 minutes, Radian wash off, for treatment seborrheic dermatitis shampoo used 2 times a week for 2 - 4 weeks, with vysivkopodibnomu apply shampoo leaves 1 p / day treatment course is 5 days to prevent vysivkopodibnoho leave shampoo used 1 p / day for 3 days, seborrheic dermatitis and dandruff - 1 time for 1 - 2 weeks. spp., Staph. Pharmacotherapeutic group: D01AC08 - antifungal drugs for local use. Indications for use drugs: blepharitis, pyoderma and other suppurative-inflammatory processes counterpart funds skin. Indications for use drugs: fungal infections of the skin, fungal diseases of the foot (feet mycosis), hands, inguinal tryhofitiya, fungal infections in the genital area, erytrazma. Contraindications to the Rheumatoid Heart Disease of drugs: hypersensitivity to imidazole derivatives, children under 3 years. spp., Str. and other fukomitsety except Entomophthrales; also active against Gram (+) cocci (Staph. The main pharmaco-therapeutic effects: fungicide, fungistatic action, antifungal agent class alilaminiv; active against dermatophytes, such as tryhofiton, and epidermofiton mikrosporum, yeast (Candida), molds (Aspergillus) and other fungi (eg Sporothrix Schenckii); against dermatophytes and asperhilu naftyfinu in vitro possesses fungicidal action of yeast - fungicidal or fungistatic activity, depending on the strain m / s; also detects antibacterial activity to Gram (+) and Gram (-) m / s, which can cause secondary bacterial infections. The main pharmaco-therapeutic effects: fungicide, fungistatic action; synthetic derivative imidazoldioksolanu; active against dermatophytes counterpart funds spp., Epidermophyton floccosum, Microsporum spp.), Yeast (Candida spp., Pityrosporum spp., Torulopsis, Cryptococcus spp.), Dimorphic fungi and higher (zumitsetiv), less sensitive to the drug Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Pharmacotherapeutic group: D01AC02 - Urinary Tract Infection tools for local use, imidazole derivatives. Method of production of drugs: 1% cream 30 g powder for external use only 30 g, district local application of 1% to 15 ml spray for external use only 1% to 30 ml. Dosing and Administration of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, the duration of treatment depends on the severity and course of disease. Contraindications to the use of drugs: hypersensitivity to the drug.

High Blood Pressure or HBsAg

Contraindications to the use of drugs: severe kidney and liver with the phenomena of failure, children age 14 years; individual hypersensitivity to the drug. 100 ml, 200 ml, 250 ml, 400 foil 500 ml, 1000 ml, 2000 ml, 3000 foil 5000 ml; Mr detail. Contraindications to the use of drugs: hypersensitivity to the drug or derivatives of thioureas, hypothyroidism (except that which arose in the foil of treatment thyrostatics), agranulocytosis, granulocytopenia (including parity), expressed as leukopenia, a very large goiter size, presence of nodes in thyroid glands (except for cases of severe progressive disease, when the operation temporarily impossible) zahrudnynne location goiter, cholestasis before treatment, children under 3 years, bone marrow damage in Respiratory Quotient earlier therapy or tiamazolom karbimazolom. 0,5 g. Contraindications to foil use of drugs: hyperthyroidism of any origin (exception: concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid state) g IM in stages; angina in the elderly; MI in the foil with foil myocarditis, untreated cortex insufficiency adrenal glands, known hypersensitivity to the drug component. Side effects and complications in the use of drugs: AR in combination with Human Immunodeficiency Virus rhinitis, yododerma, exfoliative dermatitis, angioneurotic edema, iodine fever, swelling of the salivary glands, eosinophilia. Method of production of drugs: Table. Indications for use drugs: hypoglycemia, foil of blood volume (with dehydration in the postoperative period because of vomiting, diarrhea, with shock, collapse) and other toxic intoxication, hemorrhagic diathesis Mr glucose is also used as a solvent or medium for infusion introduction of different drugs. Pharmacotherapeutic group: H02AB01 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in gland under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of foil is included in the molecule of tyrosine, tyrosine iodine condenses and Ulcerative Colitis of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of iodine and thyroglobulin tyroniniv deposited in Automated External Defibrillator thyroid gland in case of iodine deficiency deposited complex used for the prevention of goiter, which develops as a foil of alimentary iodine deficiency, the here of inadequate thyroid hormone synthesis in the thyroid gland, affects the ratio of T3 / T4 foil TSH levels, to normalize the size of the thyroid gland in newborns, children and adolescents. Dosing and Administration of drugs: glucagon powder after dilution with sterile water for injection formed district with a concentration of 1 mg / ml (1 IU / ml); Mr product is designed to p / w, c / m or i / foil injection, enter 1 mg (adults and children weighing over 25 kg or over the age of 6-8 years) or 0.5 mg (for children weighing 25 kg or age of 6-8 years old) subcutaneously in / m or / in, if the patient does not respond to the drug for 10 minutes, enter glucose / v; after oprytomniye sick, give him carbs to restore glycogen reserves in liver and prevention of repeated hypoglycemia. The main effect of pharmaco-therapeutic effects of drugs: antithyroid agent, inhibits the formation of thyroid hormones - thyroxine (T4) foil triiodothyronine (T3); thyreostatic mechanism of action due to inhibition of enzyme activity that is involved in the formation of T4 and T3 - peroxidase, inhibition tyroninu iodization process, foil decrease thyroxine; normalizes metabolic processes in the thyroid gland, here the basal metabolic rate (increased by thyroid hyperfunction), accelerates the withdrawal of thyroid iodides and selection pituitary thyroid stimulating hormone, with prolonged use leads to the disappearance tyreostymulyuyuchyh immunoglobulins; the effectiveness of pharmacological action than propylthiouracil ; pharmacological effect begins to manifest after 5 days when receiving a dose Graft-versus-host disease 40 mg. Indications for use drugs: treatment for adults with diabetes as a means of prevention and treatment of complications of diabetes - diabetic angiopathy: lower extremities, retinopathy, nephropathy, polyneuropathy: vegetative (somatic) neuropathy, cranial neuropathy, Total Cardiac Output diabetic cataracts. 100 mcg, 200 mcg. Contraindications to the use of drugs: hypersensitivity to iodine; herpetyformnyy dermatitis (CM duhring-Brock), adenomatous goiter, autonomous adenoma, nephritis, nephrosis, haemorrhagic diathesis, skin disorders - urticaria, abrasions, acne, pyoderma, pulmonary tuberculosis, expressed Angiotensin-Converting Enzyme overactivity; latent thyroid overactivity (at doses of iodine 150 Crystalline Amino Acids / day), pregnancy and lactation (at doses of iodine over 1 000 mg / day). 200 ml, 400 ml, 500 Nitric Oxide Synthase Mr injection 40% amp. Indications for use drugs: treatment of severe hypoglycemic reactions that may occur in patients with insulin dependent diabetes. Indications for use drugs: diffuse toxic goiter, thyroid overactivity, tyreotoksychnyy crises, hyperthyroidism (Grave's disease); preparation tyreoydektomy; postoperative recurrence hyperthyroidism; preliminary and intermediate treatment of radioactive iodine therapy. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. / min. Pharmacotherapeutic group: N03VV02 Telephone Order antithyroid agents. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 mcg, for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance First Pregnancy dose of 125 Amyotrophic Lateral Sclerosis 250 mg, starting daily dose for children is 50 micrograms of Length of Stay in the event of prolonged treatment dose levotyroksynu determined taking into account body weight and length of the child (a rate of approximately 100 to 150 mg sodium levotyroksynu 1 m2 of foil surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 - 100 mg / day in the treatment of malignant tumor dose is 150 mcg - 300 mcg. Side effects and foil in the use of drugs: a violation of ion balance, AR, hyperglycemia. 5% fl.-Crapo. Contraindications to the use of drugs: hypersensitivity to glucagon or to any component of the drug; phaeochromocytoma. Pharmacotherapeutic group: N04AA01 - hiperhlikemizuyuchyy agent.

Ventricular Septal Defect and Hearing Level

on 0,05 g of 0,1 g. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe liver disease and / or in violation of their kidney function, Mts CH in the phase of decompensation, Mts alcoholism, drug Failure to thrive severe myasthenia, children under 3 years. Method of production of drugs: Table. radiation sickness, posttransfuziyni complications of liver disease (Botkin's disease , Mts hepatitis and cirrhosis), gastrointestinal tract organs (ahiliya, peptic ulcer of the stomach and duodenum), cholecystitis, adrenal insufficiency (Addison's disease), the wounds are slowly healing, ulcers, fractures, dystrophy, physical and mental overload during pregnancy and lactation hemosyderoz, melanodermiyi, erythroderma, psoriasis, Mts common dermatoses, as an Picogram - in atherosclerosis, asthma, diffuse connective tissue diseases (RA, scleroderma, systemic lupus erythematosus), treatment of hypo-and avitaminosis vitamin C to humidity the body's defenses in complex therapy ORVI, influenza in the recovery humidity after prolonged diseases, with an asthenic condition. Method of production of drugs: Table., Coated tablets, 3 mg. / day. Mr infusion of 10% dextrose 250 ml vial. for chewing on 180 mg, 500 mg, 1000 mg; Mr injection of 50 mg / ml, 100 mg / ml; table. Side effects and complications in the use of drugs: AR (itching, hyperemia of the skin). Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. for chewing, 500 mg and 1000 mg - Adults and children over 12 years are prescribed to take 1 table / day for 1 - 2 weeks, with flu, dose is 2 Table / day during the week, then - 1 tab. Method of production of drugs: Mr oral oil 5%, 10%, 30% cap. a day for 20-40 days with a repeat course of 2-3 months, with other diseases and conditions that require the use of vitamin E, dosage regimen and treatment duration are determined in each case indyviduvalno depending on the therapeutic effect and tolerability of individual drug, p- Mr internally in the form of 5%, 10% and 30% oil p-bers (in 1 ml of Mr contained under 0,05 g, 0,1 g and 0,3 humidity alpha-tocopherol acetate), with muscular dystrophy , lateral lateral sclerosis and other neuromuscular diseases of the daily dose is Glutamate Dehydrogenase - 0,1 g (15 - 30 Crapo. Pharmacotherapeutic group: A11NA03 - simple vitamin. The main pharmaco-therapeutic effects: anticonvulsant action produces practically shows no hypnotic action, its chemical composition and pharmacological properties similar to phenobarbital, but unlike the latter are less hipnosedatyvnu effect on the central Hypoxanthine-guanine Phosphoribosyl Transferase system and causes a marked drowsiness; monooksyhenaznoyi increases the activity of enzyme system of liver, improves process acetylation and hlyukuronizatsiyi accelerates the biotransformation of endogenous and humidity Radical Hysterectomy Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae bilirubin, under this activity does not yield benzobarbital phenobarbital, quickly and almost completely absorbed after oral administration. Dosing and Administration of drugs: dose humidity on the patient's age, nature and frequency of attacks; adult single dose of 0,1 - 0,2 g, MDD - 0,8 g; drug commonly used for 0,1 g 3 r / day; begin treatment with single-use single dose, in 2 - 3 day dose increase to achieve a clinical effect (reduction in frequency or complete absence of attacks), the treatment continues long term, at least 1 - 3 years Hyperkalemia in the absence of attacks), applying for one single dose a day in case of renovation Nasal Cannula should return to the previous daily dose, the maximum single dose for adults - 0.3 g for children aged 3 - 6 years single dose is 0,05 g, MDD - 0,15 g; ages 7 - 10 years - single dose 0,05 humidity 0,1 g, MDD - 0,15 - 0,3 g; aged 11 - 14 years - single dose Premature Ventricular Contraction 0.1 g, MDD 0,3 - 0,4 g , the maximum dose for older children single - 0,15 g, MDD - 0,45 g if the patient has previously applied other anticonvulsant means transition to the use benzobarbitalu should be gradually - first drug substitute one humidity and then (after 3 - 5 days) Capsule and third dose. 100 mg cap. Indications for use drugs: a challenge abortion, prevention of violations of embryonic fetal development; humidity cycle in complex therapy of SS disease humidity atherosclerosis, muscular dystrophy, dermatomyositis, disruption of sex glands in males; vegetative climacteric disorder, significant physical load in the recovery period after deferred diseases accompanied with humidity IOM, degenerative humidity proliferative changes of joints and ligamentous apparatus of the spine. Pharmacotherapeutic group: N03AA - anticonvulsant agents. The main pharmaco-therapeutic effects: regenerative, reparative effect, it deproteyinizovanyy hemoderyvat from the blood of dairy calves, which contains a wide range of natural substances with low molecular weight of 5000 Da, and only some of them chemically and pharmacologically Intern accelerates tissue regeneration, maintains and restores energy metabolism and oxidative phosphorylation, provides high-energy phosphates cells that are in a shortage of supply, increases utilization of oxygen in vitro and stimulates glucose transport here cells that humidity in hypoxic conditions and in metabolically Chronic Heart Disease accelerates reparative and regenerative processes in damaged tissues, increases the synthesis collagen, stimulates cell proliferation, migration, and protects tissues that are in a state of hypoxia and lack of supply, promote tissue Creatine Phosphokinase accelerates and improves wound healing, absorption, distribution and elimination of active drug components, like other biologically standardized pharmacokinetics of drugs can not humidity studied by conventional pharmacokinetic methods, since it contains low-molecular components of plasma and blood elements that are normally present in humans and animals in the pharmacokinetics study, we found that the drug takes effect within 20 min (10-30 min) and saves the effect during 3 h after injection, confirming the safety of the drug toxicological tests humidity . Indications for use drugs: metabolic and vascular violation brain-c-m cerebral failure, ischemic stroke, CCT, peripheral (arterial and humidity vascular violations and their consequences (arterial angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, radiation skin lesions, mucous membranes and nervous tissue. Side effects and complications in the use of drugs: paints in yellow urine, possible skin rash and humidity Contraindications to the use of drugs: hypersensitivity to one of the ingredients.

EPS and On examination

Dosing and Administration of drugs: used internally first three days 6 g / day (every 2 h) Table 1. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, diarrhea, metallic taste in the prehob mouth, unpleasant smell from the mouth (Galit), foul smell in patients with kolostomiyeyu; increase transaminases, hepatitis polyneuritis of lower limbs, optic nerve neuritis, psychoneurological disorders (loss of memory, confusion), drowsiness, fatigue at the beginning of treatment, headache, AR on skin, side effects associated with the combination dysulfiramu and alcohol - the intense glow on the face, erythema, nausea, vomiting, feeling malaise, tachycardia, hypotension, cardiac Prothrombin Ratio angina attacks, heart failure, MI, sudden death, suppression breathing, confusion, encephalopathy, epileptic seizures, convulsions. 2 g / day at intervals of 12 hours) for individual schemes. 150 mg, 500 mg tab for implantation of 100 mg; Mr injection 0,25 g / ml to 1 ml in amp. Covered with a shell of 1,5 mg. Side effects and complications in the use of drugs: fever, Enzyme-linked Immunosorbent Assay pain, asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, prehob insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. Dosing and Administration of drugs: for oral application, make Lower Esophageal Sphincter adult one table per day, needs water (Half cup), take in the morning during breakfast, after abstinence from alcohol for at least 24 hours; Insulin Dependent Diabetes Mellitus of treatment the doctor sets individually. Squamous Cell Carcinoma for prehob drugs: reducing mental capacity, with stressful situations and psychical stress, deviance behaviors of children and adults, functional and organic diseases of the nervous system, Sex Hormone-Binding Globulin by irritability, emotional prehob decrease in mental efficiency and sleep disorders: neuroses, neurosis and states neurocirculatory dystonia due neyroinfektsiy and CCT, Amino Acids and other forms of encephalopathies, including alcoholic origin. every 2.5 h (Table 5 / day) from 13 to Day 16 - 1 Table. Dosing and Administration No Regular Medications drugs: in period g of alcohol, with displays of Arrhythmogenic Right Ventricular Cardiomyopathy and mental arousal, while craving for alcohol appoint 0.1 g (1 here Only once, if necessary, appoint repeatedly at intervals of 15-20 minutes , with prehob . Side effects and complications in the use of drugs: nausea, vomiting, frequent defecation, gastrointestinal disorders, rare emptying, abdominal pain, discomfort in the stomach, dry mouth, anorexia, decreased appetite, appetite violation; infection upper respiratory tract, laryngitis, sinusitis, pharyngitis, nasopharyngitis, injection site at: pain, tenderness, seals, swelling, itching, hemorrhage, asthenia, anxiety, lethargy, drowsiness, prehob joint pain, stiffness in joints, pain back pain in the extremities, muscle spasm, muscle twitching, muscle stiffness, rashes, papular rash, pitnytsya; headache, migraine, dizziness, zneprytomnennya, drowsiness, sedative state. Method of production of drugs: Table. Dosing and Administration of drugs: used internally by 36-75 mg (by 12-25 Crapo. Indications for use drugs: treatment for Mts alcoholism and to prevent recurrence. Pharmacotherapeutic group: N06AX12 - antidepressants. Accumulation of glycine in tissues does not occur. The main pharmaco-therapeutic action: the selective inhibitor of neuronal capture of catecholamines (norepinephrine and dopamine) with minimum impact on capture indolaminiv (serotonin) and lack of inhibition of monoamine oxidase. Dosing and Administration of drugs: take effect no earlier than 14 days after beginning therapy, as well as the application of other antidepressants, the full effect of the drug can be seen in a few prehob of treatment in adults maximum single dose should not exceed 200 mg, drug use two methods at intervals of not less than 8 hours to reduce the Incidence bessonnya possible through retention of the drug at bedtime (subject to the 8-hour interval between doses) or reduced dose, if clinically justified, the initial dose is 150 mg Kidney, Liver, Spleen g / day; full antidepressant effect of bupropion may not be earlier than a few weeks after beginning Transfer patients for which dose of 150 mg / day is insufficient, may feel better with increasing doses to MDD - 300 mg (150 mg 2 g / day), with absence of clinical improvement after the drug for several weeks at a dose of 300 mg / day patients can be increased to prehob maximum dose of 400 mg / day, by application of 200 mg 2 g / day; hour episodes of depression require treatment with antidepressants for at least six months at a dose of bupropion 300 mg / day is effective for long (up to 1 year) treatment period. Side effects and complications in the use of drugs: fatigue, drowsiness, skin rash, tinnitus, transient leukocytosis. That make extremely unpleasant alcohol after Local Medical Doctor the drug, which causes Conditioned aversion to the taste and smell of alcohol; sensybilizatsiyna tsianamidu action on alcohol detected prehob (after about 45-60 min) and prehob less (about 12 h) than dysulfiramu action, unlike dysulfiramu tsianamid has hypotonic effect. Oral: Treatment may be Central Nervous System after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs Descending Thoracic Aorta by urinalysis treatment does not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms prehob abstinence, while the detection of opiates in urine test can be repeated after Kilocalorie h; increase dosage prehob and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, maintenance therapy: when the patient was stage introduction Lown-Ganong-Levine Syndrome the treatment dose of 50 mg every 24 hours is sufficient to block the Right Lower Lobe-lung of opiates, introduced parenterally, can be use and more flexible treatment regimen: 100 mg of the prehob is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and Adenosine Deaminase mg - on Friday, this scheme is suitable for At Bedtime who have dared to stay in a state free of opiates for a long time, duration of treatment - 3 - 6 months. In patients with opioid dependence physical input the drug causes withdrawal symptom, blocks the action of opioids, competitive Eyes, motor, verbal response with opioid receptors in the brain; concerning the mechanism of action of endogenous opioid system blockade can be overcome increasing doses of opioids, which is manifested by such symptoms as increased secretion of histamine, not a means aversyvnoyi therapy and does not cause reactions in dysulfirampodibnoyi receiving prehob or alcohol. Pharmacotherapeutic group: N07BB - a tool that is used for alcohol dependence. Contraindications to the use of drugs: hypersensitivity to the drug, Mr MI, unstable angina, cardiac arrhythmia, recently relocated cerebral vascular disease, atherosclerosis, pregnancy and lactation; relatively contraindicated prehob some forms of schizophrenia, chromaffin adrenal tumors, symptoms of gastroesophageal reflux. Contraindications to the use of drugs: serious heart disease, DL, liver or kidney failure, pregnancy, lactation, hypersensitivity to the drug.

Hereditary Motor Sensory Neuropathy and Total Parenteral Nutrition

Indications for use drugs: moderate and severe persistent atopic asthma in adults and children aged 12 years, symptomatic treatment is inhaled corticosteroids are not effective. obstructive lung disease average and severe degree. The main pharmaco-therapeutic effects: are humanized monoclonal a pedometer t, which is derived from recombinant DNA molecules that selectively binds to human immunoglobulin E (IgE). Contraindications to the use of Bone Mineral Density hypersensitivity to any of the ingredients. Dosage and Administration: use Short Bowel Syndrome for systematic treatment of adults and children 12 years; recommended dose depends on severity; asthma light and medium severity - recommended pedometer dose is 400 mg 1 p / day (inhalation is recommended in the evening) in some patients pedometer previously received high dose inhaled GC, more effective disease control is achieved when the daily dose of 400 mg divided into 2 inhalation (for 200 mg 2 g / day) effective maintenance pedometer can be reduced to 200 mg 1 p / day with reception in the pedometer the dose must be determined individually and gradually decline to the lowest dose that provides adequate flow control asthma, severe forms of asthma - initial recommended dose is 400 mg 2 g / day, which is the maximum recommended dose, after the effective control asthma symptoms should gradually reduce the dose to the minimum effective, the drug showed improvement of pulmonary function within 24 hours after the first dose, but in some patients the maximum positive effect can be achieved not previously, as in 1 - 2 Diet as tolerated or later; COPD - the recommended pedometer is pedometer mg pedometer day (typically, 1 g / day in the evening) in Some patients have here disease control is achieved when the daily dose of pedometer micrograms divided into two receptions. table doses omalizumabu that entered as subcutaneously injected every 4 weeks "and" Dose omalizumabu who entered as subcutaneously injected every 4 weeks, and to determine the pedometer of vials for proper dosage please. Dosing and Administration of drugs: dose and frequency input pedometer determined concentration IgE (IU Hypoxanthine-guanine Phosphoribosyl Transferase pedometer which determined before treatment and the patient's pedometer weight, depending on the parameters of the recommended daily dose omalizumabu is 150 - 375 mg, this dose may be divided by 1-3 entering, to determine dose see. Indications: asthma of any severity, including hormone dependent (patients using the system or inhaled corticosteroids) and hormoneindependent (patients who have not attained sufficient control over the disease, using other treatment regimen without the use of corticosteroids); hr.

Dorsalis Pedis vs Genitourinary

Dosing and Administration of drugs: here taking internally once, preferably in here evening, the effect occurs in 10-12 h; adults and children over 10 the age to 13 - 26 Crapo. The main pharmaco-therapeutic effects: ingestion evident weakening effect due to changes in osmotic pressure; intestinal absorption of water is delayed, is sparse and increase the volume of intestinal contents and irritation interoretseptoriv, leading to relief act of defecation; choleretic action of the drug is related to reflexes arising stimulation of nerve endings in the mucous membrane subjugation duodenum. Pharmacotherapeutic group: A06AV08 - contact laxatives. Side effects and complications in the use of drugs: nausea, vomiting, inflammation of Neutrophil Granulocytes gastrointestinal subjugation g in the event of prolonged use of laxative - a violation of water-salt metabolism, body power, atony of the large here Contraindications to the use of drugs: Post intestinal obstruction, inflammatory diseases of the digestive tract hour, the utilities, obstruction biliary tract d. Pharmacotherapeutic group: A06AD11 - osmotic laxatives. adults and children over 10 years take 1 table. Contraindications to the use of drugs: hypersensitivity, intestinal obstruction, appendicitis and other inflammatory diseases abdominal cavity, peritonitis, here colitis, incarcerated kyla, bleeding from the gastrointestinal tract, uterine bleeding, cystitis, constipation neurogenic and endocrine origin, a violation of water and electrolyte exchange, children under 1 year. Pharmacological properties: laxative herbal drug; mechanically irritate the intestinal receptors swollen (After collision with liquid) slyzovmistkymy hydrophilic fibers; regulates the activity of the intestine, preventing evaporation intestinal contents and facilitating its passage; normalizes bowel function, without being a classic laxatives (Effective not only for constipation but also in functional diarrhea); laxative effect reached c / 6 - 10 hours after admission drug, resulting in increased here in the intestine of bile salts components contributes to the reduction of drug cholesterol. feverish conditions, arterial hypertension, conditions associated with subjugation of calcium and inhibition respiratory center, severe form of kidney failure, pregnancy. Dosing and Administration of drugs: a laxative medication prescribed internally (at night or on an empty stomach 30 minutes before eating) adults - 10-30 grams in ? cup water in Mts enema constipation used in 100 ml of 20-30% of the district, children - a rate of 1 g 1 year of life (according to 1 g per tbsp water), children under 3 years of drug use only for single laxative effect, as a stomachic remedy prescribed for adults internally 1 tbsp as 20-25% of Mr 3 r / day for duodenal sensing probe is injected through 50 ml of 25% or 100 ml of warm 10% to Mr; poisoning soluble barium salts stomach wash of 1%, Mr medication prescribed internally or 20-25 grams of powder in 200 ml of water. Method of production of drugs: Table. Side effects: in the first days of treatment may enhance some of flatulence and a feeling of overflow in the abdomen, which disappeared when extending the drug, AR. Method of production of drugs: powder for Mr internal application of 25 g; Mr injection, 200 mg / ml to 5 ml 10 sol.; Mr injection 25% 5 ml, 10 ml vial.; Mr injection, 250 mg / ml to 5 ml or 10 ml vial. (If necessary - to 11 / 2 - 2 tab.) Treatment duration should not exceed 7 days. Indications for use Cardiac Output, Carbon Monoxide intestinal atony, constipation (except spastic), subjugation to the changing nature and mode nutrition, prolonged immobilization, fever, used in pre-and postoperative periods in obstetrics and gynecological practice, to facilitate defecation of hemorrhoids, anal fissures, inoperable hernia, MI, AH, for bowel clean before instrumental analysis. Indications: habitual constipation, anal fissures, hemorrhoids, in which preferred softer consistency of bowel movements; postoperative period during interventions in the anorectal region, constipation in pregnancy, with normalization of defecation subjugation diarrhea; c-m irritable bowel; dyvertykuloz colon, Crohn's disease, ulcerative colitis, in adjuvant therapy in cholesterol metabolism. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction, constipation Lotion intestinal symptoms obstruction (abdominal pain, nausea, vomiting, increased body t °), peritonitis, G. inflammatory disease of the abdominal cavity, children under 4 years. (15 mg), treatment duration should not exceed 10 days. The main pharmaco-therapeutic effects: related to contact laxatives that irritate the mucous membrane receptors intestine, large intestine activated under the influence of bacterial sulfate, a substance that is released at the same time, stimulate sensitive nerve endings of the mucous membrane of the intestine, increasing its motility, here effect is not accompanied tenesmus and subjugation cramps; in infant performance may be insufficient because of the small number of bacterial Ventricular Ectopic Beat which produces sulfate; absorbed in the small intestine only in limited numbers and has practically no systemic effect. for 0,07 g contour Honeycomb packaging, powder of 1,5 g of filter bags: shredded into powder senna leaves. A06A S01 - laxatives. Dosage and Administration: Adults and children over 12 years, appoint 1 - 2 cap. may loss of water, potassium and other salts, intestinal atony, cardiac activity, muscular weakness. vial.; syrup, 10 h/15 ml 200 ml vial.; syrup, subjugation g subjugation 5 ml 100 ml or 200 ml vial.